These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 20299167

  • 1. Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
    Kikura-Hanajiri R, Kawamura M, Miyajima A, Sunouchi M, Goda Y.
    Forensic Sci Int; 2010 May 20; 198(1-3):62-9. PubMed ID: 20299167
    [Abstract] [Full Text] [Related]

  • 2. The prevalence of MDMA/MDA in both hair and urine in drug users.
    Han E, Yang W, Lee J, Park Y, Kim E, Lim M, Chung H.
    Forensic Sci Int; 2005 Aug 11; 152(1):73-7. PubMed ID: 15939177
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous analysis of six amphetamines and analogues in hair, blood and urine by LC-ESI-MS/MS. Application to the determination of MDMA after low ecstasy intake.
    Chèze M, Deveaux M, Martin C, Lhermitte M, Pépin G.
    Forensic Sci Int; 2007 Aug 06; 170(2-3):100-4. PubMed ID: 17629643
    [Abstract] [Full Text] [Related]

  • 4. Urinary excretion profiles of N-hydroxy-3,4-methylenedioxymethamphetamine in rats.
    Tsujikawa K, Mikuma T, Kuwayama K, Miyaguchi H, Kanamori T, Iwata YT, Inoue H.
    Xenobiotica; 2011 Jul 06; 41(7):578-84. PubMed ID: 21425955
    [Abstract] [Full Text] [Related]

  • 5. High performance liquid chromatographic assays of the illicit designer drug "Ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding.
    Garrett ER, Seyda K, Marroum P.
    Acta Pharm Nord; 1991 Jul 06; 3(1):9-14. PubMed ID: 1677250
    [Abstract] [Full Text] [Related]

  • 6. Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry.
    Mortier KA, Dams R, Lambert WE, De Letter EA, Van Calenbergh S, De Leenheer AP.
    Rapid Commun Mass Spectrom; 2002 Jul 06; 16(9):865-70. PubMed ID: 11948818
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H, Katagi M, Miki A, Shima N, Kamata T, Nishikawa M, Nakajima K, Tsuchihashi H.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May 25; 819(2):315-22. PubMed ID: 15833296
    [Abstract] [Full Text] [Related]

  • 11. Fatality due to the use of a designer drug MDMA (Ecstasy).
    Kłys M, Rojek S, Woźniak K, Rzepecka-Woźniak E.
    Leg Med (Tokyo); 2007 Jul 25; 9(4):185-91. PubMed ID: 17320458
    [Abstract] [Full Text] [Related]

  • 12. Determination of 3,4-methylenedioxymethamphetamine and its five main metabolites in rat urine by solid-phase extraction and high performance liquid chromatography with on line mass spectrometry.
    Menet MC, Fonsart J, Hervé F, Fompeydie D, Galliot-Guilley M, Noble F, Scherrmann JM.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct 15; 878(28):2905-10. PubMed ID: 20843750
    [Abstract] [Full Text] [Related]

  • 13. In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques.
    Lim HK, Foltz RL.
    Biol Mass Spectrom; 1991 Nov 15; 20(11):677-86. PubMed ID: 1686830
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of MDMA and its metabolites in urine by GC and GC/MS].
    Shen M, Yan W, Shen B, Xiang P, Huang Z, Liu W, Bo J.
    Fa Yi Xue Za Zhi; 1998 Nov 15; 14(1):10-1, 24, 61. PubMed ID: 11360579
    [Abstract] [Full Text] [Related]

  • 15. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats.
    Matsushima K, Nagai T, Kamiyama S.
    J Anal Toxicol; 1998 Nov 15; 22(1):33-9. PubMed ID: 9491966
    [Abstract] [Full Text] [Related]

  • 16. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
    Kikura R, Nakahara Y, Mieczkowski T, Tagliaro F.
    Forensic Sci Int; 1997 Jan 17; 84(1-3):165-77. PubMed ID: 9042722
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
    da Silva DG, de Pinho PG, Pontes H, Ferreira L, Branco P, Remião F, Carvalho F, Bastos ML, Carmo H.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar 15; 878(9-10):815-22. PubMed ID: 20167546
    [Abstract] [Full Text] [Related]

  • 20. Quantification of MDMA and MDA in abusers' hair samples by semi-micro column HPLC with fluorescence detection.
    Nakamura S, Tomita M, Wada M, Chung H, Kuroda N, Nakashima K.
    Biomed Chromatogr; 2006 Mar 15; 20(6-7):622-7. PubMed ID: 16779783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.